MIRA PHARMACEUTICALS INC (MIRA)
Common Stock
MIRA PHARMACEUTICALS INC
NASDAQ:MIRA (5/17/2024, 7:13:20 PM)
After market: 0.65 -0.01 (-0.76%)0.655
-0.02 (-3.61%)
Company Profile
Mira Pharmaceuticals Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Baltimore, Maryland and currently employs 1 full-time employees. The company went IPO on 2023-08-03. MIRA Pharmaceuticals, Inc. is a clinical development stage biopharmaceutical company. The firm is focused on the development and commercialization of molecular synthetic cannabinoid analog for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. The firm is developing its product candidate, MIRA1a, for the treatment of neuropsychiatric, inflammatory and neurologic diseases and disorders. MIRA1a is a synthetic cannabinoid analog for treating anxiety and chronic pain by striking a balance between the beneficial effects of tetrahydrocannabinol (THC) and cannabidiol (CBD) by targeting the cannabinoid type 1 and type 2 (CB1 and CB2) receptors.
Company Info
MIRA PHARMACEUTICALS INC
855 N Wolfe Street #623-6
Baltimore MARYLAND
P: 18133695150
Employees: 1
Website: https://mirapharmaceuticals.com/
MIRA News
6 days ago - InvestorPlaceMIRA Stock Earnings: Mira Pharmaceuticals Misses EPS for Q1 2024MIRA stock results show that Mira Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024.
6 days ago - BusinessInsiderMIRA Stock Earnings: Mira Pharmaceuticals Misses EPS for Q1 2024InvestorPlace - Stock Market News, Stock Advice & Trading Tips Mira Pharmaceuticals (NASDAQ:MIRA) just reported results for the first quarter ...
2 months ago - InvestorPlaceMIRA Stock Earnings: Mira Pharmaceuticals Beats EPS for Q4 2023MIRA stock results show that Mira Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023.
2 months ago - BusinessInsiderMIRA Stock Earnings: Mira Pharmaceuticals Beats EPS for Q4 2023InvestorPlace - Stock Market News, Stock Advice & Trading Tips Mira Pharmaceuticals (NASDAQ:MIRA) just reported results for the fourth quarter...
2 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayIt's time to dive into the biggest pre-market stock movers for Wednesday morning as we check out all of the hottest news!
2 months ago - MIRA Pharmaceuticals, Inc.MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor/PRNewswire/ -- MIRA Pharmaceuticals Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), an innovative pre-clinical-stage pharmaceutical company focused on the...
MIRA Twits
Here you can normally see the latest stock twits on MIRA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
